James Casper
Overview
Explore the profile of James Casper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bride K, Vincent T, Smith-Whitley K, Lambert M, Bleesing J, Seif A, et al.
Blood
. 2015 Oct;
127(1):17-28.
PMID: 26504182
Patients with autoimmune multilineage cytopenias are often refractory to standard therapies requiring chronic immunosuppression with medications with limited efficacy and high toxicity. We present data on 30 patients treated on...
2.
Marsh R, Rao K, Satwani P, Lehmberg K, Muller I, Li D, et al.
Blood
. 2012 Nov;
121(6):877-83.
PMID: 23131490
There have been no studies on patient outcome after allogeneic hematopoietic cell transplantation (HCT) in patients with X-linked inhibitor of apoptosis (XIAP) deficiency. To estimate the success of HCT, we...
3.
Verbsky J, Baker M, Grossman W, Hintermeyer M, Dasu T, Bonacci B, et al.
J Clin Immunol
. 2011 Nov;
32(1):82-8.
PMID: 22068910
Severe combined immunodeficiency is a life-threatening primary immune deficiency characterized by low numbers of naïve T cells. Early diagnosis and treatment of this disease decreases mortality. In 2008, Wisconsin began...
4.
Kamani N, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, et al.
Biol Blood Marrow Transplant
. 2011 Jun;
17(12):1783-9.
PMID: 21658461
We describe the incidence of malignancy in patients with primary immunodeficiency disorders (PIDD) following hematopoietic cell transplantation (HCT). From the Center for International Blood and Marrow Transplant Research, 2266 PIDD...
5.
Davies S, Wang D, Wang T, Arora M, Ringden O, Anasetti C, et al.
Biol Blood Marrow Transplant
. 2009 Feb;
15(3):360-6.
PMID: 19203727
Unrelated donor (URD) bone marrow transplantation (BMT) is an effective treatment for leukemia in children, but its success is threatened by graft-versus-host disease (GVHD) and relapse. In this report, we...
6.
Pavletic S, Carter S, Kernan N, Henslee-Downey J, Mendizabal A, Papadopoulos E, et al.
Blood
. 2005 Jul;
106(9):3308-13.
PMID: 16046530
Donor-derived T cells have been proposed to play a role in pathogenesis of chronic graft-versus-host disease (cGVHD). The impact of ex vivo T-cell depletion (TCD) on cGVHD was analyzed in...
7.
Bunin N, Carston M, Wall D, Adams R, Casper J, Kamani N, et al.
Blood
. 2002 Apr;
99(9):3151-7.
PMID: 11964277
Allogeneic bone marrow transplantation (BMT) may be curative for more patients than chemotherapy for the child with relapsed acute lymphoblastic leukemia. This study reviewed the outcomes of 363 children with...